Next Article in Journal
Overexpression of StCDPK13 in Potato Enhances Tolerance to Drought Stress
Previous Article in Journal
c-Myc and FOXO3a—The Everlasting Decision Between Neural Regeneration and Degeneration
Previous Article in Special Issue
Differential Expression of Mitogen-Activated Protein Kinase Signaling Pathways in the Human Choroid–Retinal Pigment Epithelial Complex Indicates Regional Predisposition to Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Blue Light-Induced Mitochondrial Oxidative Damage Underlay Retinal Pigment Epithelial Cell Apoptosis

1
Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada
2
The MUHC-McGill University Ocular Pathology & Translational Research Laboratory, McGill University, Montreal, QC H4A 3J1, Canada
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(23), 12619; https://doi.org/10.3390/ijms252312619
Submission received: 20 October 2024 / Revised: 20 November 2024 / Accepted: 22 November 2024 / Published: 24 November 2024
(This article belongs to the Special Issue Molecular Mechanisms of Retina Degeneration)

Abstract

:
Reactive oxygen species (ROS) play a pivotal role in apoptosis. We reported that Blue Light (BL) induced oxidative stress in human retinal pigment epithelial (RPE) cells in vitro and increased drusen deposition and RPE cell apoptosis in human eyes. Here, we investigated the mechanisms underlying BL-induced damage to RPE cells. Cells were exposed to BL with or without the antioxidant N-acetylcysteine. Cells were analyzed for levels of ROS, proliferation, viability, and mitochondria membrane potential (ΔΨM) fluctuation. We performed proteomic analyses to search for differentially expressed proteins. ROS levels increased following RPE cell exposure to BL. While ROS production did not affect RPE cell proliferation, it was accompanied by decreased ΔΨM and increased cell apoptosis due to the caspase cascade activation in a ROS-dependent manner. Proteomic analyses revealed that BL decreased the levels of ROS detoxifying enzymes in exposed cells. We conclude that BL-induced oxidative stress is cytotoxic to RPE cells. These findings bring new insights into the involvement of BL on RPE cell damage and its role in the progression of age-related macular degeneration. The use of antioxidants is an avenue to block or delay BL-mediated RPE cell apoptosis to counteract the disease progression.

1. Introduction

Age-related macular degeneration (AMD) is a progressive degenerative disease affecting the macula with subsequent irreversible vision loss [1,2,3]. Aside from genetic predisposing mutations, inflammation, smoking, and diet, the primary risk factor for disease development remains age, as it reaches 4% of individuals below the age of 50 but more than 27% of 80-year-old people [1,4]. Affected individuals suffer from considerable deterioration of their sharp central vision. This results from gradual failure of the Bruch’s membrane, choroidal capillaries, and retinal pigment epithelial (RPE) cells with ensuing dysfunction of photoreceptors [5,6]. On the other hand, AMD is linked to high socioeconomic issues, which constitutes a heavy charge on the health system regarding patients’ care [7,8].
AMD presents in wet form, which accounts for 15% of cases. It is due to growing capillaries that invade the subretinal space with subsequent leakage that induces hemorrhage. Patients in this cohort benefit from treatments that target neovascularization. The disease could also develop as a non-exudative dry form that concerns 85% of cases. This form develops following (i) drusen deposition underneath the macula between the Bruch’s membrane and the RPE layer and (ii) lipofuscin accumulation in RPE cells. For this form of the disease, there is no approved treatment, which requires a better understanding of the disease to identify new therapeutic targets [6,9,10,11,12,13,14].
Light was reported as another risk factor for the development and progression of AMD, mostly the dry form as RPE cell-stored lipofuscin, increased cell sensitivity to different spectra [1,15,16]. Ultraviolet (UV) and blue light (BL) wavelengths induce photooxidative stress and photochemical damage to exposed cells. Specifically, BL triggers RPE cell senescence and death [1,16,17,18,19,20,21,22,23,24,25]. In the eye, the cornea and the lens crystalline block UV spectra. Instead, the BL spectra diffuse through these structures, reach the retina and the underneath tissues, and affect their proper functioning [23]. During aging, the lens progressively turns yellowish, which buffers BL radiation entering the eye and protects the posterior eye structures [26,27]. Nonetheless, this naturally protective effect is lost during lens removal or replacement [28,29,30].
Oxidative stress and apoptosis are linked physiological phenomena. ROS and mitochondria play pivotal roles in the apoptotic cascade induction under both physiological and pathologic conditions [31,32,33]. In the context of AMD, we reported that BL induced oxidative stress and subsequent cytotoxicity to cultured human RPE cells and increased drusen deposition that triggered oxidative stress and RPE cell apoptosis in human cadaveric eye specimens [29,30,34,35]. The use of BL-filtering devices mitigated these effects. Here, we determined the mechanisms behind BL-induced damage to RPE cells. While increased ROS levels did not affect RPE cell proliferation, it induced a significant decrease in mitochondrial membrane potential and an increase in RPE cell apoptosis. BL-induced RPE cell apoptosis resulted from the activation of the caspase cascade in a ROS-dependent manner. The proteomic analyses revealed that BL decreased the expression levels of several ROS detoxifying enzymes in exposed RPE cells that will prolong the oxidative stress in these cells with a maintenance of the BL cytotoxic effects. Together, our findings bring new insights into the involvement of BL on RPE cell damage and its putative role in the progression of AMD. Filtering these radiations or the use of antioxidants are avenues to block or delay BL-mediated RPE cell apoptosis to counteract the disease progression.

2. Results

2.1. BL-Induced Oxidative Stress in RPE Cells

In this study, we used A2E-loaded ARPE-19 cells and human primary RPE cells (Figure S1) [34]. RPE cells were exposed to BL under a Solar Simulator to normalize in vitro light exposure to sunlight reaching the eye in vivo. We found that BL exposure significantly increased the levels of total cellular ROS and mitochondrial superoxide anion in both primary RPE cells and ARPE-19 cells (Figure 1 and Figure S2). These data show that BL induces oxidative stress in human RPE cells.

2.2. BL Is Cytotoxic to RPE Cells in a ROS-Dependent Manner

We reported that BL affected RPE cell growth, which might be due to an effect on cell proliferation or cell viability [34]. Here, we first investigated cell proliferation and found that BL did not affect RPE cell proliferation as assessed by cell cycle (Figure 2a and Figure S3). When we studied the effects of BL on cell viability, we found that it significantly increased RPE cell apoptosis, while it did not affect cell necrosis (Figure 2b and Figure S3). To determine whether BL-induced cytotoxic effects were linked to increased ROS production, we pretreated cells with the ROS scavenger NAC. We found that quenching ROS production abolished BL-induced apoptosis. This indicates that BL-elicited oxidative stress triggered apoptotic cell death in RPE cells.

2.3. BL Induces ΔΨM Collapse and Caspase Pathway Activation

It is well recognized that mitochondrial respiratory chain, oxidative stress, and cell growth are linked physiological processes [31,32,33]. Specifically, ROS production and ΔΨM defect drive apoptotic cascade induction. We determined the molecular mechanism links underlaying BL-induced oxidative stress and cytotoxic effects in RPE cells. We assessed ΔΨM and found that BL exposure significantly reduced it by 55% to 60% in primary RPE cells and ARPE-19 cells, respectively (Figure 3 and Figure S4). These effects were reduced following pre-treatment of cells with NAC.
As ΔΨM collapse is accompanied by caspase activation; we verified this apoptosis-inducing pathway. We observed that BL exposure increased by ~2–4 times the levels of activated caspases 9/3/7 (Figure 4 and Figure S5). Interestingly, all these effects were prevented following NAC pre-treatment of RPE cells, which stipulates that BL-induced oxidative stress in RPE cells triggers ΔΨM collapse and subsequent activation of caspase cascade-mediated apoptosis.

2.4. BL Decreased the Expression of ROS Detoxifying Enzymes in RPE Cells

To determine putative factors associated with BL effects on RPE cells, we performed proteomic analyses. We identified 2810 proteins, of which 1404 (50%) were detected in all analyzed RPE samples (Table S1). High percentages of detected proteins were shared between non-treated cells (71.1–78.3%) and between BL-exposed cells (67.7–79.6%) (Figure 5a(i,ii)). In addition, non-exposed and BL-exposed cells shared 2369 proteins, while 288 and 153 proteins were exclusively present in one or other samples, respectively (Figure 5a (insert) and Table S1). As a readout for the cell origin of analyzed proteins, we detected a panel of proteins that are specific markers of RPE (Table 1).
Notably, we found that 44 proteins were upregulated and 129 proteins were downregulated in BL-exposed cells (Tables S2 and S3). We focused our analyses on factors involved in cellular response to oxidative stress (Table S4). We found that many ROS detoxifying enzymes were down-regulated in BL-exposed cells (Figure 5b,c).
To identify physiological processes to which the identified proteins are related, we clustered the most differentially expressed proteins into gene ontology categories. Characterization by biological process highlighted categories consistent with response to oxidative stress and cellular response to stress in proteins down-expressed in BL-treated cells (i.e., ETFDH, GSS, PXDN, and PRDX6; 5.3-fold decrease). In contrast, highly expressed in BL-treated cells clustered in categories consistent with apoptotic signaling and NHEJ-associated DNA repair pathways (i.e., ANXA5, HSPA5, PRKDC, THBS1, SLC25A5, SLC25A6 and TP53BP1; 32.4-fold enrichment) (Figure 6). This is in line with our findings that BL elicited ROS-mediated apoptosis and produced ROS-induced DNA damage that caused the activation of the DNA repair machinery.

3. Discussion

BL is a risk factor for AMD [15]. We reported that it induced oxidative stress in RPE cells in vitro [34] and increased drusen deposition that triggered RPE cell apoptosis in human eyes [29,30,35]. In this study, we determined molecular mechanisms underlying BL-induced damage to primary human RPE cells. Using a Solar Simulator, we normalized in vitro light exposure to light reaching the retina in vivo [36]. While this remains an artificial model and condition, it helps in understanding the behavior of RPE cells under sunlight-like illumination. BL increased ROS levels in RPE cells, eliciting a collapse in the ΔΨM, and increasing apoptosis following caspase activation. Also, BL decreased detoxifying enzyme expression, which sustains oxidative stress and cytotoxic effects.
Light exposure is toxic to many tissues and underlies many diseases [37,38,39,40,41,42,43,44]. We reported on its involvement in the pathogenesis of uveal melanoma [45,46,47,48]. It is also responsible for other ocular diseases (cataract and AMD) [15,16,49]. While UV radiations are blocked by the cornea and lens, visible light crosses these tissues and reaches posterior eye structures [23,50,51]. Of these high-energy radiations, BL displays the most cytotoxic effects on RPE cells [16,17,18,19,20,21,22,24,25,52,53]. We deepen these observations using primary RPE cells from aged donors and by demonstrating a direct link between BL-induced ROS production and RPE cell cytotoxicity. The use of antioxidants rescued RPE cells from BL-induced damage (Figure 7). Notably, following BL exposure, the levels of cellular ROS increased more than seven times. Instead, the levels of the mitochondrial superoxide anion increased by only two times, due to the fact that this unstable intermediate is readily converted to more stable metabolites [54].
Increased ROS levels induce mitochondrial DNA damage and dysfunction, and subsequent cellular damage. This triggers various degenerative pathologies, such as AMD [55]. We found that BL induced ΔΨM collapse, activated caspase cascade, and caused cell apoptosis in a ROS-dependent manner. Therefore, mitochondrial dysfunction is likely to play an important role in the induction of the observed RPE cell apoptosis due to ROS production. Antioxidant mechanisms are suppressed in A2E-loaded RPE cells [16,56]. Our proteomic analyses showed that BL significantly reduced the levels of many antioxidant enzymes that might exacerbate RPE cell cytotoxicity. It should be highlighted that ROS may target different cellular components (i.e., proteins, lipids, DNA) to induce, for example, lipid peroxidation or DNA damage that culminate in cell dysfunctions.
During aging, RPE cells face different insults, such as light and oxidative stress. BL induces lipofuscin deposition and subretinal drusen accumulation [57,58]. During the visual cycle, these light-absorbing structures are processed by RPE cells. In order for photoreceptors to work effectively, outer segments need to be replaced daily, and RPE cells act as the recycling station for this phagocytosis-associated process [59,60]. That way, they ensure that debris does not build up underneath the retina. Phagocytized outer segments are digested in RPE lysosomes, but this reaction is hampered by oxidative stress. Subsequently, undigested residues form A2E-rich lipofuscin that has an absorbance peak at 350–435 nm. This increases RPE cell photosensitization and triggers a vicious circle [17,61,62,63,64,65]. In addition, deposition of drusen during aging causes a failure in the hydraulic conductivity and RPE cell malnutrition, with subsequent neurodegeneration [66]. We mimicked this situation in vitro by using ARPE-19 cells charged with synthetic A2E. We found that BL effects on these cells were almost the same as on primary cells.
Based on our findings, many therapeutic avenues for AMD are possible. Interventions that counteract oxidative stress were shown to be beneficial in the treatment of many diseases [67,68,69,70]. Application of this strategy is promising, as antioxidants are already used in ophthalmologic clinics. Alteration of mitochondrial functions suggests that it may be a potential target for disease prevention. Mitochondrial stimulation protects RPE cells from oxidative damage [67,68,69,70,71]. Following cataract surgery, the protective function against BL of the age-associated yellowing lens is lost [26,27]. The recent use of the BL-filtering intraocular lenses to replace the natural lens crystalline was reported to restore this deficiency by reducing the levels of produced ROS and RPE cell mortality [34,72,73]. These devices filter the “bad” BL (below 460 nm) but not the “good” BL (above 460 nm) that is involved in the regulation of the circadian rhythm [19,74,75]. Photobiomodulation (PBM), a process that regulates physiological conditions following light exposure, promotes cellular fitness. PBM is currently used in physiotherapy, arthritis, wound repair, and sports medicine [76,77,78]. It acts through the activation of the mitochondrial respiratory chain with subsequent normalization of cellular functions (i.e., proliferation, survival, and cytoprotection) [76]. Recently, PBM was shown to have beneficial effects for AMD as it induced a reduction in the size and number of Drusen [79,80,81]. Its action could also pass through the regulation of oxidative stress and mitochondrial function at the level of RPE cells.

4. Materials and Methods

4.1. Human Eye Procurement for Primary RPE Cell Isolation and Cell Culture

Human eyes (n = 6, 3 males and 3 females, 65–76-years-old) were obtained from the Centre Hospitalier Universitaire de Québec (Canada), following informed consent from the donor’s next of kin, and were used in accordance with a protocol approved by the ethic board of the RI-MUHC (#2019–5314) and with The Code of Ethics of the World Medical Association.
Primary RPE cell cultures were established as reported previously [34,82]. In all experiments, cells were used between the second and fourth passages (exponential growth phase and presence of cytoplasmic pigmented granules) (Figure S1) [83]. ARPE-19 cell line was obtained from Cedarlane (ON., Canada) and was maintained in DMEM-F12 medium supplemented with 10% FBS and antibiotics (Corning, AZ, USA). These cells were used for all experiments at early passages (˂20). As reported previously, ARPE-19 cells were loaded with A2E (20 µM) 24 h before exposure to light [34].

4.2. Cell Exposure to BL

Cells were exposed to BL when they reached 70% confluence. Cultures were maintained in the dark wrapped in aluminum foil at 37 °C and 5% CO2. Cell culture medium was removed, replaced with D-PBS supplemented with calcium and magnesium, and cells were exposed under a solar simulator (TSS-156R, OAI, OAInet, Milpitas, CA, USA) set at 30 mW/cm2 for 30 min in the presence or absence of NAC. NAC (1 mM; Sigma-Aldrich, St. Louis, MO, USA) was added to cells 24 h before exposure to BL and during BL exposure. A Blue Dichroic Filter (Edmund Optics Inc., Bengaluru, India) was used to allow only BL to pass and reach cells (Figure S1).

4.3. Reactive Oxygen Species (ROS) Detection

We analyzed both total cellular ROS and mitochondrial superoxide anions using DCF-DA and MitoSox Red probes, respectively, according to manufacturer protocols (ThermoFisher, Waltham, MA, USA). Fluorescence was read using an Infinite M200 Pro microplate reader (Tecan, Mennedorf, Switzerland). Reading parameters were introduced manually to normalize fluorescence measurements between experiments.

4.4. Cell Cycle and Apoptosis Analyses

For cell cycle analyses, cells were fixed in ice-cold ethanol (70%) for 2 h and labeled with propidium iodide (PI (50 μg/mL); Sigma Aldrich, St. Louis, MO, USA). Cells were acquired in a BD FACSCanto II flow cytometer at ~400 events/second flow rate. Doublets were excluded by creating a combination of FSC-channel bivariate plots using Area vs. Height parameters. For apoptosis analysis, we used the Alexa Fluor 488 Annexin V/Dead Cell Kit (ThermoFisher, Waltham, MA, USA) following the manufacturer’s instructions. ~20.000 cells were acquired per sample at ~500 events/second rate. Analyses were performed using FlowJo software (version 10.10) [84,85].

4.5. Mitochondria Membrane Potential (ΔΨM) Measurement

ΔΨM was assessed using the JC-1 probe according to the manufacturer’s instructions (Cayman, MI, USA). Fluorescence was read using the Infinite M200 Pro microplate reader. Two measures were performed at Ex/Em (535/595 nm and 485/535 nm) for red J-aggregates and green monomers, respectively. Data were presented as ratio of J-aggregates to monomer values.

4.6. Western Blot and Mass Spectrometry (MS) Proteomic Analyses, and Database Search

For MS analyses, cell samples were resuspended in PBS. Cell preparations for Western Blot were homogenized in RIPA containing protease inhibitors (Sigma Aldrich, St. Louis, MO, USA) at 4°C for 30 min.
For immunoblotting, proteins were resolved in precast polyacrylamide gel and transferred to PVDF membranes (Bio-Rad, Hercules, CA, USA). Membranes were probed with rabbit anti-caspase 9 (cleaved Asp353) (ThermoFisher, Waltham, MA, USA) and mouse anti-β-actin (Sigma Aldrich, St. Louis, MO, USA) antibodies, followed by HRP-conjugated goat anti-rabbit and goat anti-mouse antibodies (Sigma Aldrich, Waltham, MA, USA). Protein signals were visualized using ECL prime Western Blot detection (Sigma Aldrich, St. Louis, MO, USA) in a ChemiDoc System (BioRad, Hercules, CA, USA). Densitometric analysis was performed using ImageJ software (version 1.54g).
Liquid chromatography-tandem mass spectrometry proteomic analyses were performed on protein samples as previously described [86,87]. Raw data were converted into *.mgf format (Mascot generic format) to use the Mascot2.6.2 search engine to search against human protein sequences (Uniprot 2019). Database search results were loaded onto Scaffold 4.10.0 for spectral counting, statistical treatment, data visualization and quantification. Samples with low total protein counts and low spectrum counts were excluded from the analyses. A p-value cut-off of 0.05 and a fold-value change of ≥2 were used to identify the differentially expressed proteins. The identified protein list in Scaffold was exported to Microsoft Excel sheets and uploaded into the DAVID Bioinformatics database (v2023q4) for the analysis of functional gene enrichment and annotation (gene ontology analyses). In addition, bioinformatic analyses were performed using the FunRich software (version 3.1.3).

4.7. Caspases 3/7 Activation Analyses

Caspase pathway activation was analyzed using the CellEvent Caspase-3/7 probe (ThermoFisher, Waltham, MA, USA) as per the manufacturer’s protocol. Following staining, cells were mounted with coverslips in Mounting Medium with DAPI (Vectorlabs, MA, USA) and visualized using an LSM780 confocal microscope (Zeiss, Jena, Germany).

4.8. Statistical Analyses

All experiments were performed with 6 independent primary RPE cell cultures or at least 3 independent ARPE-19 cell cultures. Data were compared using an ANOVA followed by the Dunnett post hoc test for multiple comparisons with one control group. A p value < 0.05 was considered statistically significant.

5. Conclusions

BL exposure elicits oxidative stress in RPE cells that triggers mitochondrial damage and cell apoptosis. Quenching ROS produced following BL exposure provides protective effects to these cells. Proposed strategies for counteracting the deleterious effects of BL boil down to blocking these radiations or targeting their downstream cellular effects. Overall, our findings give a rationale for the use of multiple strategies to prevent the eye’s posterior segment and mainly the RPE layer from BL deleterious effects.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms252312619/s1.

Author Contributions

Conceptualization, M.A. and M.N.B.; methodology, M.A., Y.C. and A.G.; formal analysis, M.A., Y.C. and A.G.; investigation, M.A., Y.C. and A.G.; resources, M.N.B.; data curation, M.A. and M.N.B.; writing—original draft preparation, M.A.; writing—review and editing, M.A., Y.C., A.G. and M.N.B.; supervision, M.N.B.; project administration, M.N.B.; funding acquisition, M.N.B. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by Alcon Research LLC (#196608b). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of RI-MUHC (protocol code 2019–5314, last approval December 2023).

Informed Consent Statement

Informed consent was obtained from all donor’s next of kin. Written informed consent has been obtained to publish this paper.

Data Availability Statement

Research data will be shared upon formal request.

Acknowledgments

We would like to acknowledge the technical expertise and scientific support of the Drug Discovery Platform of RI-MUHC for A2E synthesis, especially Anne-Laure Larroque and Sanjoy Kumar-Das. We would also like to acknowledge the technical support of the Proteomics facility of the RI-MUHC, especially Lorne Taylor and Amy Wong.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Joachim, N.; Mitchell, P.; Burlutsky, G.; Kifley, A.; Wang, J.J. The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study. Ophthalmology 2015, 122, 2482–2489. [Google Scholar] [CrossRef] [PubMed]
  2. Ferris, F.L. Senile macular degeneration:review of epidemiologic features. Am. J. Epidemiol. 1983, 118, 132–151. [Google Scholar] [CrossRef] [PubMed]
  3. Heesterbeek, T.J.; Lorés-Motta, L.; Hoyng, C.B.; Lechanteur, Y.T.E.; den Hollander, A.I. Risk factors for progression of age-related macular degeneration. Ophthalmic Physiol. Opt. 2020, 40, 140–170. [Google Scholar] [CrossRef] [PubMed]
  4. Wong, W.L.; Su, X.; Li, X.; Cheung, C.M.; Klein, R.; Cheng, C.Y.; Wong, T.Y. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Health 2014, 2, e106–e116. [Google Scholar] [CrossRef]
  5. Ding, X.; Patel, M.; Chan, C.C. Molecular pathology of age-related macular degeneration. Prog. Retin. Eye Res. 2009, 28, 1–18. [Google Scholar] [CrossRef]
  6. Fleckenstein, M.; Mitchell, P.; Freund, K.B.; Sadda, S.; Holz, F.G.; Brittain, C.; Henry, E.C.; Ferrara, D. The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology 2018, 125, 369–390. [Google Scholar] [CrossRef]
  7. Kim, S.; Park, S.J.; Byun, S.J.; Park, K.H.; Suh, H.S. Incremental economic burden associated with exudative age-related macular degeneration: A population-based study. BMC Health Serv. Res. 2019, 19, 828. [Google Scholar] [CrossRef]
  8. Marques, A.P.; Ramke, J.; Caims, J.; Butt, T.; Zhang, J.H.; Muirhead, D.; Jones, I.; Tong, B.A.; Swenor, B.K.; Faal, H.; et al. Global economic productivity losses from vision impairment and blindness. eClinical Med. 2021, 35, 100852. [Google Scholar] [CrossRef]
  9. Sarks, J.P.; Sarks, S.H.; Killingsworth, M.C. Evolution of geographic atrophy of the retinal pigment epithelium. Eye 1988, 2 Pt 5, 552–577. [Google Scholar] [CrossRef]
  10. Zarbin, M.A.; Casaroli-Marano, R.P.; Rosenfeld, P.J. Age-related macular degeneration: Clinical findings, histopathology and imaging techniques. Dev. Ophthalmol. 2014, 53, 1–32. [Google Scholar]
  11. Kennedy, C.J.; Rakoczy, P.E.; Constable, I.J. Lipofuscin of the retinal pigment epithelium: A review. Eye 1995, 9 Pt 6, 763–771. [Google Scholar] [CrossRef] [PubMed]
  12. Khan, K.N.; Mahroo, O.A.; Khan, R.S.; Mohamed, M.D.; McKibbin, M.; Bird, A.; Michaelides, M.; Tufail, A.; Moore, A.T. Differentiating drusen: Drusen and drusen-like appearances associated with ageing, AMD, inherited eye disease and other pathological processes. Prog. Retin. Eye Res. 2016, 53, 70–106. [Google Scholar] [CrossRef] [PubMed]
  13. Estarreja, J.; Mendes, P.; Silva, C.; Camacho, P.; Mateus, V. Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. Pharmaceuticals 2024, 17, 1000. [Google Scholar] [CrossRef] [PubMed]
  14. Parr, T.; Friston, K.J. The active construction of the visual world. Neuropsychologia 2017, 104, 92–101. [Google Scholar] [CrossRef]
  15. Klein, B.E.K.; Howard, K.P.; Iyengar, S.K.; Sivakumaran, T.A.; Meyers, K.J.; Cruickshanks, K.J.; Klein, R. Sunlight exposure, pigmentation, and incident age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2014, 55, 5855–5861. [Google Scholar] [CrossRef]
  16. Wielgus, A.R.; Collier, R.J.; Martin, E.; Lih, F.B.; Tomer, K.B.; Chignell, C.F.; Roberts, J.E. Blue light induced A2E oxidation in rat eyes-experimental animal model of dry AMD. Photochem. Photobiol. Sci. 2010, 9, 1505–1512. [Google Scholar] [CrossRef]
  17. Sparrow, J.R.; Cai, B. Blue light-induced apoptosis of A2E-containing RPE: Involvement of caspase-3 and protection by Bcl-2. Invest. Ophthalmol. Vis. Sci. 2001, 42, 1356–1362. [Google Scholar]
  18. Abokyi, S.; To, C.-H.; Lam, T.T.; Tse, D.Y. Central role of oxidative stress in age-related macular degeneration: Evidence from a review of the molecular mechanisms and animal models. Oxid. Med. Cell Longev. 2020, 2020, 7901270. [Google Scholar] [CrossRef]
  19. Marie, M.; Bigot, K.; Angebault, C.; Barrau, C.; Gondouin, P.; Pagan, D.; Fouquet, S.; Villette, T.; Sahel, J.-A.; Lenaers, G.; et al. Light action spectrum on oxidative stress and mitochondrial damage in A2E-loaded retinal pigment epithelium cells. Cell Death Dis. 2018, 9, 287. [Google Scholar] [CrossRef]
  20. Ozkaya, E.K.; Anderson, G.; Dhillon, B.; Bagnaninchi, P.O. Blue-light induced breakdown of barrier function on human retinal epithelial cells is mediated by PKC-ζ over-activation and oxidative stress. Exp. Eye Res. 2019, 189, 107817. [Google Scholar] [CrossRef]
  21. Taylor, H.R.; West, S.; Muñoz, B.; Rosenthal, F.S.; Bressler, S.B.; Bressler, N.M. The long-term effects of visible light on the eye. Arch. Ophthalmol. 1992, 110, 99–104. [Google Scholar] [CrossRef] [PubMed]
  22. Tejedor, J.V.; Marchena, M.; Ramirez, L.; García-Ayuso, D.; Gómez-Vicente, V.; Sánchez-Ramos, C.; de la Villa, P.; Germain, F. Removal of the blue component of light significantly decreases retinal damage after high intensity exposure. PLoS ONE 2018, 13, e0194218. [Google Scholar]
  23. Cohen, F.B.; Baillet, G.; de Ayguavives, T.; Garcia, P.O.; Krutmann, J.; Peña-García, P.; Reme, C.; Wolffhn, J.S. Ultraviolet damage to the eye revisited: Eye-sun protection factor (E-SPF®), a new ultraviolet protection label for eyewear. Clin. Ophthalmol. 2014, 8, 87–104. [Google Scholar]
  24. Vila, N.; Siblini, A.; Esposito, E.; Bravo-Filho, V.; Zoroquiain, P.; Aldrees, S.; Logan, P.; Arias, L.; Burnier, M.N. Blue-light filtering alters angiogenic signaling in human retinal pigmented epithelial cells culture model. BMC Ophthalmol. 2017, 17, 198. [Google Scholar] [CrossRef]
  25. Alaimo, A.; Linares, G.G.; Bujjamer, J.M.; Gorojod, R.M.; Alcon, S.P.; Martínez, J.H.; Baldessari, A.; Grecco, H.E.; Kotler, M.L. Toxicity of blue led light and A2E is associated to mitochondrial dynamics impairment in ARPE-19 cells: Implications for age-related macular degeneration. Arch. Toxicol. 2019, 93, 1401–1415. [Google Scholar] [CrossRef]
  26. Mellerio, J. Yellowing of the human lens: Nuclear and cortical contributions. Vision Res. 1987, 27, 1581–1587. [Google Scholar] [CrossRef]
  27. Werner, J.S.; Schefrin, B.E.; Bradley, A. Optics and vision of the aging eye. In Handbook of Optics, 3rd ed.; Bass, M., Enoch, J.M., Eds.; McGraw Hill: New York, NY, USA, 2010; Volume 3, pp. 14.11–14.38. [Google Scholar]
  28. Cruickshanks, K.J.; Klein, R.; Klein, B.E.K.; Nondahl, D.M. Sunlight and the 5-Year Incidence of Early Age-Related Maculopathy-The Beaver Dam Eye Study. Arch. Ophthalmol. 2001, 119, 246–250. [Google Scholar]
  29. Mastromonaco, C.; Bergeron, S.; Coblentz, J.; Abdouh, M.; Burnier, J.V.; Burnier, M.N. Drusen Quantification of Eye Bank Eyes Implanted with or without Blue-Light Filtering IOLs: A Histopathological Study. Invest. Ophthalmol. Vis. Sci. 2021, 62, 2719. [Google Scholar]
  30. Nassrallah, E.I.B.; Mastromonaco, C.; Marcotte, E.; Youhnovska, E.; Abdouh, M.; Burnier, M.N. Drusen classification and quantification in pseudophakic postmortem eyes implanted with or without blue-light filtering intraocular lenses. Pan-Am. J. Ophthalmol. 2024, 6, 63. [Google Scholar] [CrossRef]
  31. Simon, H.U.; Haj-Yehia, A.; Levi-Schaffer, F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000, 5, 415–418. [Google Scholar] [CrossRef]
  32. Redza-Dutordoir, M.; Averill-Bates, D.A. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim. Biophys. Acta 2016, 1863, 2977–2992. [Google Scholar] [CrossRef] [PubMed]
  33. Morse, P.T.; Arroum, T.; Wan, J.; Pham, L.; Vaishnav, A.; Bell, J.; Pavelich, L.; Malek, M.H.; Sanderson, T.H.; Edwards, B.F.P.; et al. Phosphorylations and Acetylations of Cytochrome c Control Mitochondrial Respiration, Mitochondrial Membrane Potential, Energy, ROS, and Apoptosis. Cells 2024, 13, 493. [Google Scholar] [CrossRef] [PubMed]
  34. Abdouh, M.; Lu, M.; Chen, Y.; Goyeneche, A.; Burnier, J.V.; Burnier, M.N., Jr. Filtering blue light mitigates the deleterious effects induced by the oxidative stress in human retinal pigment epithelial cells. Exp. Eye Res. 2022, 217, 108978. [Google Scholar] [CrossRef] [PubMed]
  35. Youhnovska, E.; Goyeneche, A.A.; Nassrallah, E.I.B.; Bergeron, S.; Dias, A.S.; Burnier, M.N. Immunohistochemical analysis of RPE cell viability atop drusen in enucleation and evisceration specimens. Invest. Ophthalmol. Vis. Sci. 2022, 63, 3042-F0413. [Google Scholar]
  36. Arnault, E.; Barrau, C.; Nanteau, C.; Gondouin, P.; Bigot, K.; Viénot, F.; Gutman, E.; Fontaine, V.; Villette, T.; Cohen-Tannoudji, D.; et al. Phototoxic Action Spectrum on a Retinal Pigment Epithelium Model of Age-Related Macular Degeneration Exposed to Sunlight Normalized Conditions. PLoS ONE 2013, 8, e71398. [Google Scholar] [CrossRef]
  37. Mancebo, S.E.; Wang, S.Q. Skin cancer: Role of ultraviolet radiation in carcinogenesis. Rev. Environ. Health 2014, 29, 265–273. [Google Scholar] [CrossRef]
  38. Mallet, J.D.; Gendron, S.P.; Desgarnier, D.M.C.; Rochette, P.J. Implication of ultraviolet light in the etiology of uveal melanoma: A review. Photochem. Photobiol. 2014, 90, 15–21. [Google Scholar] [CrossRef]
  39. Watson, M.; Holman, D.M.; Maguire-Eisen, M. Ultraviolet Radiation Exposure and Its Impact on Skin Cancer Risk. Semin. Oncol. Nurs. 2016, 32, 241–254. [Google Scholar] [CrossRef]
  40. Sample, A.; He, Y.Y. Mechanisms and prevention of UV-induced melanoma. Photodermatol. Photoimmunol. Photomed. 2018, 34, 13–24. [Google Scholar] [CrossRef]
  41. Teng, Y.; Yu, Y.; Li, S.; Huang, Y.; Xu, D.; Tao, X.; Fan, Y. Ultraviolet Radiation and Basal Cell Carcinoma: An Environmental Perspective. Front. Public. Health. 2021, 9, 666528. [Google Scholar] [CrossRef]
  42. Kim, Y.; He, Y.Y. Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation. Genes. Dis. 2014, 1, 188–198. [Google Scholar] [CrossRef] [PubMed]
  43. Branisteanu, D.C.; Bogdanici, C.M.; Branisteanu, D.E.; Maranduca, M.A.; Zemba, M.; Balta, F.; Branisteanu, C.I.; Moraru, A.D. Uveal melanoma diagnosis and current treatment options (Review). Exp. Ther. Med. 2021, 22, 1428. [Google Scholar] [CrossRef] [PubMed]
  44. Soliman, N.; Mamdouh, D.; Elkordi, A. Choroidal Melanoma: A Mini Review. Medicines 2023, 10, 11. [Google Scholar] [CrossRef]
  45. Marshall, J.C.; Gordon, K.D.; McCauley, C.S.; de Souza Filho, J.P.; Burnier, M.N. The effect of blue light exposure and use of intraocular lenses on human uveal melanoma cell lines. Melanoma Res. 2006, 16, 537–541. [Google Scholar] [CrossRef]
  46. Fernandes, B.F.; Marshall, J.C.; Burnier, M.N., Jr. Blue light exposure and uveal melanoma. Ophthalmology 2006, 113, 1062. [Google Scholar] [CrossRef]
  47. Di Cesare, S.; Maloney, S.; Fernandes, B.F.; Martins, C.; Marshall, J.-C.; Antecka, E.; Odashiro, A.N.; Dawson, W.W.; Burnier, M.N. The effect of blue light exposure in an ocular melanoma animal model. J. Exp. Clin. Cancer Res. 2009, 28, 48. [Google Scholar] [CrossRef]
  48. Logan, P.; Bernabeu, M.; Ferreira, A.; Burnier, M.N., Jr. Evidence for the Role of Blue Light in the Development of Uveal Melanoma. J. Ophthalmol. 2015, 2015, 386986. [Google Scholar]
  49. Ni, Y.; Zhang, H.; Chu, L.; Zhao, Y. m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases. Antioxidants 2023, 12, 510. [Google Scholar] [CrossRef]
  50. Sliney, D.H. How light reaches the eye and its components. Int. J. Toxicol. 2002, 21, 501–509. [Google Scholar] [CrossRef]
  51. Sliney, D.H. Exposure geometry and spectral environment determine photobiological effects on the human eye. Photochem. Photobiol. 2005, 81, 483–489. [Google Scholar]
  52. Dillon, J.; Zheng, L.; Merriam, J.C.; Gaillard, E.R. Transmission of light to the aging human retina: Possible implications for age related macular degeneration. Exp. Eye Res. 2004, 79, 753–759. [Google Scholar] [CrossRef]
  53. Sparrow, J.R.; Miller, A.S.; Zhou, J. Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. J. Cataract. Refract. Surg. 2004, 30, 873–878. [Google Scholar] [CrossRef] [PubMed]
  54. Loschen, G.; Azzi, A.; Richter, C.; Flohe, L. Superoxide radicals as precursors of mitochondrial hydrogen peroxide. FEBS Lett. 1974, 42, 68–72. [Google Scholar] [CrossRef] [PubMed]
  55. Kowalczyk, P.; Sulejczak, D.; Kleczkowska, P.; Bukowska-Ośko, I.; Kucia, M.; Popiel, M.; Wietrak, E.; Kramkowski, K.; Wrzosek, K.; Kaczyńska, K. Mitochondrial Oxidative Stress-A Causative Factor and Therapeutic Target in Many Diseases. Int. J. Mol. Sci. 2021, 22, 13384. [Google Scholar] [CrossRef] [PubMed]
  56. Shamsi, F.A.; Boulton, M. Inhibition of RPE lysosomal and antioxidant activity by the age pigment lipofuscin. Invest. Ophthalmol. Vis. Sci. 2001, 42, 3041–3046. [Google Scholar]
  57. Hoffman, J.D.; van Grinsven, M.J.; Li, C.; Brantley, M.; McGrath, J.; Agarwal, A.; Scott, W.K.; Schwartz, S.G.; Kovach, J.; Pericak-Vance, M.; et al. Genetic Association Analysis of Drusen Progression. Invest. Ophthalmol. Vis. Sci. 2016, 57, 2225–2231. [Google Scholar] [CrossRef]
  58. Różanowska, M.B. Lipofuscin, Its Origin, Properties, and Contribution to Retinal Fluorescence as a Potential Biomarker of Oxidative Damage to the Retina. Antioxidants 2023, 12, 2111. [Google Scholar] [CrossRef]
  59. Caceres, P.S.; Rodriguez-Boulan, E. Retinal pigment epithelium polarity in health and blinding diseases. Curr. Opin. Cell Biol. 2020, 62, 37–45. [Google Scholar] [CrossRef]
  60. Feeney-Burns, L.; Hilderbrand, E.S.; Eldridge, S. Aging human RPE: Morphometric analysis of macular, equatorial, and peripheral cells. Invest. Ophthalmol. Vis. Sci. 1984, 25, 195–200. [Google Scholar]
  61. Sparrow, J.R.; Fishkin, N.; Zhou, J.; Cai, B.; Jang, Y.P.; Krane, S.; Itagaki, Y.; Nakanishi, K. A2E, a byproduct of the visual cycle. Vis. Res. 2003, 43, 2983–2990. [Google Scholar] [CrossRef]
  62. Różanowska, M.; Pawlak, A.; Rozanowski, B.; Skumatz, C.; Zarȩba, M.; Boulton, M.E.; Burke, J.M.; Sarna, T.; Simon, J.D. Age-related changes in the photoreactivity of retinal lipofuscin granules: Role of chloroform-insoluble components. Invest. Ophthalmol. Vis. Sci. 2004, 45, 1052–1060. [Google Scholar] [CrossRef]
  63. Sparrow, J.R.; Boulton, M. RPE lipofuscin and its role in retinal pathobiology. Exp. Eye Res. 2005, 80, 595–606. [Google Scholar] [CrossRef] [PubMed]
  64. Sparrow, J.R.; Nakanishi, K.; Parish, C.A. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest. Ophthalmol. Vis. Sci. 2000, 41, 1981–1989. [Google Scholar] [PubMed]
  65. Ng, K.P.; Gugiu, B.; Renganathan, K.; Davies, M.W.; Gu, X.; Kim, S.R.; Różanowska, M.B.; Bonilha, V.L.; Rayborn, M.E.; Salomon, R.G.; et al. Retinal Pigment Epithelium Lipofuscin Proteomics. Mol. Cell Proteom. 2008, 7, 1397–1405. [Google Scholar] [CrossRef] [PubMed]
  66. Moore, D.J.; Hussain, A.A.; Marshall, J. Age-related variation in the hydraulic conductivity of Bruch’s membrane. Invest. Ophthalmol. Vis. Sci. 1995, 36, 1290–1297. [Google Scholar]
  67. Sheu, S.J.; Liu, N.C.; Ou, C.C.; Bee, Y.-S.; Chen, S.-C.; Lin, H.-C.; Chan, J.Y.H. Resveratrol stimulates mitochondrial bioenergetics to protect retinal pigment epithelial cells from oxidative damage. Invest. Ophthalmol. Vis. Sci. 2013, 54, 6426–6438. [Google Scholar] [CrossRef]
  68. Bapary, M.A.J.; Takano, J.I.; Soma, S.; Sankai, T. Effect of blue light-emitting diode light and antioxidant potential in a somatic cell. Cell Biol. Int. 2019, 43, 1296–1306. [Google Scholar] [CrossRef]
  69. Suarez-Bario, C.; del Olmo-Aguado, S.; Garcia-Perez, E.; de la Fuente, M.; Muruzabal, F.; Anitua, E.; Baamonde-Arbaiza, B.; Fernández-Vega-Cueto, L.; Fernández-Vega, L.; Merayo-Lloves, J. Antioxidant Role of PRGF on RPE Cells after Blue Light Insult as a Therapy for Neurodegenerative Diseases. Int. J. Mol. Sci. 2020, 21, 1021. [Google Scholar] [CrossRef]
  70. Yang, P.M.; Cheng, K.C.; Yuan, S.H.; Wung, B.S. Carbon monoxide-releasing molecules protect against blue light exposure and inflammation in retinal pigment epithelial cells. Int. J. Mol. Med. 2020, 46, 1096–1106. [Google Scholar] [CrossRef]
  71. Schniertshauer, D.; Wespel, S.; Bergemann, J. Natural Mitochondria Targeting Substances and Their Effect on Cellular Antioxidant System as a Potential Benefit in Mitochondrial Medicine for Prevention and Remediation of Mitochondrial Dysfunctions. Curr. Issues Mol. Biol. 2023, 45, 3911–3932. [Google Scholar] [CrossRef]
  72. Edwards, K.H.; Gibson, G.A. Intraocular lens short wavelength light filtering. Clin. Exp. Optom. 2010, 93, 390–399. [Google Scholar] [CrossRef]
  73. Hui, S.; Yi, L.; Fengling, Q.L. Effects of light exposure and use of intraocular lens on retinal pigment epithelial cells in vitro. Photochem. Photobiol. 2009, 85, 966–969. [Google Scholar] [CrossRef] [PubMed]
  74. Youn, H.Y.; Chou, B.R.; Cullen, A.P.; Sivak, J.G. Effects of 400 nm, 420 nm, and 435.8 nm radiations on cultured human retinal pigment epithelial cells. J. Photochem. Photobiol. B 2009, 95, 64–70. [Google Scholar] [CrossRef] [PubMed]
  75. Tahkamo, L.; Partonen, T.; Pesonen, A.K. Systematic review of light exposure impact on human circadian rhythm. Chronobiol. Int. 2019, 36, 151–170. [Google Scholar] [CrossRef] [PubMed]
  76. Passarella, S.; Karu, T. Absorption of monochromatic and narrow band radiation in the visible and near IR by both mitochondrial and non-mitochondrial photoacceptors results in photobiomodulation. J. Photochem. Photobiol. B 2014, 140, 344–358. [Google Scholar] [CrossRef]
  77. Ferraresi, C.; Parizotto, N.A.; Pires de Sousa, M.V.; Kaippert, B.; Huang, Y.Y.; Koiso, T.; Bagnato, V.S.; Hamblin, M.R. Light-emitting diode therapy in exercise-trained mice increases muscle performance, cytochrome c oxidase activity, ATP and cell proliferation. J. Biophotonics. 2015, 8, 740–754. [Google Scholar] [CrossRef]
  78. Hall, A.; Liedhegner, E. 670 nm Photobiomodulation Modulates Bioenergetics and Oxidative Stress in an In Vitro Model of Diabetic Retinopathy; Euretina: Paris, France, 2019. [Google Scholar]
  79. Gopalakrishnan, S.; Mehrvar, S.; Maleki, S.; Schmitt, H.; Summerfelt, P.; Dubis, A.M.; Abroe, B.; Connor, T.B., Jr.; Carroll, J.; Huddleston, W.; et al. Photobiomodulation preserves mitochondrial redox state and is retinoprotective in a rodent model of retinitis pigmentosa. Sci. Rep. 2020, 10, 20382. [Google Scholar] [CrossRef]
  80. Ivandic, B.T.; Ivandic, T. Low-level laser therapy improves vision in a patient with retinitis pigmentosa. Photomed. Laser Surg. 2014, 32, 181–184. [Google Scholar] [CrossRef]
  81. Markowitz, S.N.; Devenyi, R.G.; Munk, M.R.; Croissant, C.L.; Tedford, S.E.; Rückert, R.; Walker, M.G.; Patino, B.E.; Chen, L.; Nido, M.; et al. A double-masked, randomized, sham-controlled, single center study with photobiomodulation for the treatment of dry age-related macular degeneration. Retina 2020, 40, 1471–1482. [Google Scholar] [CrossRef]
  82. Valtink, M.; Engelmann, K. Serum-free cultivation of adult normal human choroidal melanocytes. Graefe’ Arch. Clin. Exp. Ophthalmol. 2007, 245, 1487–1494. [Google Scholar] [CrossRef]
  83. Kernt, M.; Hirneiss, C.; Wolf, A.; Liegl, R.; Rueping, J.; Neubauer, A.; Alge, C.; Ulbig, M.; Gandorfer, A.; Kampik, A.; et al. Indocyanine green increases light-induced oxidative stress, senescence, and matrix metalloproteinases 1 and 3 in human RPE cells. Acta Ophthalmol. 2012, 90, 571–579. [Google Scholar] [CrossRef]
  84. Zhou, S.; Abdouh, M.; Arena, V.; Arena, M.; Arena, G.O. Reprogramming Malignant Cancer Cells toward a Benign Phenotype following Exposure to Human Embryonic Stem Cell Microenvironment. PLoS ONE 2017, 12, e0169899. [Google Scholar] [CrossRef]
  85. Fausto de Souza, D.; Tsering, T.; Burnier, M.N.; Bravo-Filho, V.; Dias, A.B.T.; Abdouh, M.; Goyeneche, A.; Burnier, J.V. Acetylsalicylic Acid Exerts Potent Antitumor and Antiangiogenic Effects in Cutaneous and Uveal Melanoma Cell Lines. Ocul. Oncol. Pathol. 2020, 6, 442–455. [Google Scholar] [CrossRef] [PubMed]
  86. Tsering, T.; Laskaris, A.; Abdouh, M.; Bustamante, P.; Parent, S.; Jin, E.; Ferrier, S.T.; Arena, G.; Burnier, J.V. Uveal Melanoma-Derived Extracellular Vesicles Display Transforming Potential and Carry Protein Cargo Involved in Metastatic Niche Preparation. Cancers 2020, 12, 2923. [Google Scholar] [CrossRef] [PubMed]
  87. Abdouh, M.; Floris, M.; Gao, Z.H.; Arena, V.; Arena, M.; Arena, G.O. Colorectal cancer-derived extracellular vesicles induce transformation of fibroblasts into colon carcinoma cells. J. Exp. Clin. Cancer Res. 2019, 38, 257. [Google Scholar] [CrossRef] [PubMed]
Figure 1. BL-induced oxidative stress in primary RPE cells. Primary human RPE cells were exposed to BL for 30 min. (a) Cells were analyzed for the production of total cellular ROS using the DCF-DA probe. (b) Cells were analyzed for the production of mitochondrial superoxide anion using the MitoSox Red probe. Data are presented as mean ± SD (n = 6 independent experiments each repeated in quadruplicates, ** p ˂ 0.01, *** p ˂ 0.001).
Figure 1. BL-induced oxidative stress in primary RPE cells. Primary human RPE cells were exposed to BL for 30 min. (a) Cells were analyzed for the production of total cellular ROS using the DCF-DA probe. (b) Cells were analyzed for the production of mitochondrial superoxide anion using the MitoSox Red probe. Data are presented as mean ± SD (n = 6 independent experiments each repeated in quadruplicates, ** p ˂ 0.01, *** p ˂ 0.001).
Ijms 25 12619 g001
Figure 2. BL-induced RPE cells apoptosis in a ROS-dependent manner. Primary human RPE cells were exposed to BL for 30 min. (a) 24 h post-BL exposure, cells were labeled with propidium iodide (PI) and analyzed for their proliferation. Representative cell cycle phase distribution histograms are shown where the first peak (at 50 k) corresponds to cells in the G1 phase, the second peak (at 100 k) corresponds to cells in the G2/M, and area in between the peaks represents cells in the S phase. The graph displays the percentages of cells in these different phases of cell cycle as analyzed using FlowJo software (v10.10). (b) 6 h post-BL exposure, cells were labeled with Annexin V and PI and analyzed for the percentages of apoptotic cells by flow cytometry. Representative Annexin V/PI density plots are shown that display live cells (left-lower quadrants), apoptotic cells (right-lower quadrant), secondary apoptotic cells (right-upper quadrant) and necrotic cells (left-upper quandrant). The numbers represent the percentages of cells in the respective quadrants as analyzed using FlowJo software. The graph displays means of the percentages of primary apoptotic, secondary apoptotic and necrotic cells. Data are presented as mean ± SD (n = 6 independent experiments, * p < 0.05, ** p ˂ 0.01).
Figure 2. BL-induced RPE cells apoptosis in a ROS-dependent manner. Primary human RPE cells were exposed to BL for 30 min. (a) 24 h post-BL exposure, cells were labeled with propidium iodide (PI) and analyzed for their proliferation. Representative cell cycle phase distribution histograms are shown where the first peak (at 50 k) corresponds to cells in the G1 phase, the second peak (at 100 k) corresponds to cells in the G2/M, and area in between the peaks represents cells in the S phase. The graph displays the percentages of cells in these different phases of cell cycle as analyzed using FlowJo software (v10.10). (b) 6 h post-BL exposure, cells were labeled with Annexin V and PI and analyzed for the percentages of apoptotic cells by flow cytometry. Representative Annexin V/PI density plots are shown that display live cells (left-lower quadrants), apoptotic cells (right-lower quadrant), secondary apoptotic cells (right-upper quadrant) and necrotic cells (left-upper quandrant). The numbers represent the percentages of cells in the respective quadrants as analyzed using FlowJo software. The graph displays means of the percentages of primary apoptotic, secondary apoptotic and necrotic cells. Data are presented as mean ± SD (n = 6 independent experiments, * p < 0.05, ** p ˂ 0.01).
Ijms 25 12619 g002
Figure 3. BL reduced the mitochondrial membrane potential in a ROS-dependent manner. Primary human RPE cells were exposed to BL for 30 min, and cells were stained with JC-1 probe. Fluorescence of J-aggregates and J-monomers were measured. Data are expressed as the ratio between the 2 measures and are presented as mean ± SD (n = 6 independent experiments each repeated in quadruplicates, * p < 0.05, ** p ˂ 0.01.
Figure 3. BL reduced the mitochondrial membrane potential in a ROS-dependent manner. Primary human RPE cells were exposed to BL for 30 min, and cells were stained with JC-1 probe. Fluorescence of J-aggregates and J-monomers were measured. Data are expressed as the ratio between the 2 measures and are presented as mean ± SD (n = 6 independent experiments each repeated in quadruplicates, * p < 0.05, ** p ˂ 0.01.
Ijms 25 12619 g003
Figure 4. BL increased caspase cascade activation in ROS-dependent manner. Primary human RPE cells were exposed to BL for 30 min. (a) Proteins extracts were analyzed by immunoblot for the activation of Caspase 9. β-actin and red ponceau staining were used as calibrators for proteins loading. The graph shows the levels of caspases activation in the corresponding samples. Data are expressed as the densitometer values relative to the value in control sample set at 1. (b) Cells were loaded with CellEvent Caspase 3/7 Green. Pictures were acquired using a LSM780 confocal microscope. The graph displays the levels of caspases 3 and 7 activation in the corresponding samples. Data are expressed as mean fluorescence intensity (MFI) measured in an Infinite M200 Pro microplate reader relative to the value in control sample set at 1. Data are presented as mean ± SD (n = 3–5 independent RPE cells samples). * p < 0.05, ** p < 0.01.
Figure 4. BL increased caspase cascade activation in ROS-dependent manner. Primary human RPE cells were exposed to BL for 30 min. (a) Proteins extracts were analyzed by immunoblot for the activation of Caspase 9. β-actin and red ponceau staining were used as calibrators for proteins loading. The graph shows the levels of caspases activation in the corresponding samples. Data are expressed as the densitometer values relative to the value in control sample set at 1. (b) Cells were loaded with CellEvent Caspase 3/7 Green. Pictures were acquired using a LSM780 confocal microscope. The graph displays the levels of caspases 3 and 7 activation in the corresponding samples. Data are expressed as mean fluorescence intensity (MFI) measured in an Infinite M200 Pro microplate reader relative to the value in control sample set at 1. Data are presented as mean ± SD (n = 3–5 independent RPE cells samples). * p < 0.05, ** p < 0.01.
Ijms 25 12619 g004
Figure 5. BL decreased the expression levels of ROS detoxifying enzymes. Primary human RPE cells were exposed to BL for 30 min. (a) Venn diagram analyses. Samples datasets were compared for shared proteins between non-exposed cells (CTL), between BL-exposed cells (BL), and between exposed and non-exposed cells. In the insert, CTL and BL-exposed RPE cells shared 2369 proteins, while 288 and 153 proteins were exclusively present in CTL and BL-exposed RPE cells, respectively (see Supplementary Table S1 for the full list of proteins). (b) Volcano plot representation of proteins significantly and differentially expressed between CTL and BL-exposed RPE cells (See Supplementary Tables S2 and S3 for the respective protein lists). For statistical analyses, we set the analysis for a T-Test with a significant level at 0.05). ■: Significant, ●: Nonsignificant. (c) Table showing a short list of ROS detoxifying enzymes which expression is decreased in BL-exposed cells. In Orange lines are shown differentially and significantly expressed proteins. In Green are shown proteins with decreased expression levels in BL-exposed cells but not reaching the statistical significance (See Supplementary Table S4 for the full list of identified proteins). Data are obtained from the analysis of 5 RPE cell lines derived from 5 different eye donors.
Figure 5. BL decreased the expression levels of ROS detoxifying enzymes. Primary human RPE cells were exposed to BL for 30 min. (a) Venn diagram analyses. Samples datasets were compared for shared proteins between non-exposed cells (CTL), between BL-exposed cells (BL), and between exposed and non-exposed cells. In the insert, CTL and BL-exposed RPE cells shared 2369 proteins, while 288 and 153 proteins were exclusively present in CTL and BL-exposed RPE cells, respectively (see Supplementary Table S1 for the full list of proteins). (b) Volcano plot representation of proteins significantly and differentially expressed between CTL and BL-exposed RPE cells (See Supplementary Tables S2 and S3 for the respective protein lists). For statistical analyses, we set the analysis for a T-Test with a significant level at 0.05). ■: Significant, ●: Nonsignificant. (c) Table showing a short list of ROS detoxifying enzymes which expression is decreased in BL-exposed cells. In Orange lines are shown differentially and significantly expressed proteins. In Green are shown proteins with decreased expression levels in BL-exposed cells but not reaching the statistical significance (See Supplementary Table S4 for the full list of identified proteins). Data are obtained from the analysis of 5 RPE cell lines derived from 5 different eye donors.
Ijms 25 12619 g005
Figure 6. Gene ontology classification of proteomic data for differentially expressed proteins in primary RPE cells exposed or not to BL. The most enriched categories in biological processes, as analyzed by the DAVID bioinformatics platform, are shown. Data were collected from protein preparations obtained from five patient-derived RPE cells.
Figure 6. Gene ontology classification of proteomic data for differentially expressed proteins in primary RPE cells exposed or not to BL. The most enriched categories in biological processes, as analyzed by the DAVID bioinformatics platform, are shown. Data were collected from protein preparations obtained from five patient-derived RPE cells.
Ijms 25 12619 g006
Figure 7. BL-induced RPE cell apoptosis model. BL-mediated oxidative stress triggered mitochondrial damage and concomitant caspase cascade activation. These effects induced RPE cell apoptosis, that could be reversed by antioxidants (i.e., N-acetyl cysteine; NAC).
Figure 7. BL-induced RPE cell apoptosis model. BL-mediated oxidative stress triggered mitochondrial damage and concomitant caspase cascade activation. These effects induced RPE cell apoptosis, that could be reversed by antioxidants (i.e., N-acetyl cysteine; NAC).
Ijms 25 12619 g007
Table 1. List of read-out proteins in RPE cells analyzed samples.
Table 1. List of read-out proteins in RPE cells analyzed samples.
Identified ProteinsAlternate IDMolecular Function
Keratin 8KRT8Scaffold protein binding
Keratin 18KRT18Scaffold protein binding
Tight junction protein -1ZO-1Cell–cell adhesion, tight junction
Tight junction protein-2ZO-2Cell–cell adhesion, tight junction
Retinal dehydrogenase 1ALDH1A1Retinol metabolic process
Cell retinoic acid-binding protein 2CRABP2Retinoic acid biosynthetic process
All-trans-retinol 13,14-reductaseRETSATRetinol metabolic process
Retinol dehydrogenase 11RDH11Retinol metabolic process
Retinoid-inducible carboxypeptidaseSCPEP1Retinoic acid metabolic process
All-trans-retinol dehydrogenase [NAD]ADH1BRetinoic acid metabolic process
Retinol dehydrogenase 14RDH14NADP-retinol dehydrogenase activity
Plasma membrane calcium-transportingATP2B4Aging, neural retina development
Plasma membrane calcium-transportingATP2B1Aging, neural retina development
Solute carrier family 2SLC2A1Photoreceptor cell maintenance
Lysosomal protective proteinCTSAChaperone-mediated autophagy
Lysosome membrane glycoproteinLAMP2Protein complex assembly
Lysosomal Pro-X carboxypeptidasePRCPEnergy/glucose homeostasis
Lysosomal acid phosphataseACP2Lysosome organization
Lysosomal alpha-mannosidaseMAN2B1Cell proteins modification process
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Abdouh, M.; Chen, Y.; Goyeneche, A.; Burnier, M.N. Blue Light-Induced Mitochondrial Oxidative Damage Underlay Retinal Pigment Epithelial Cell Apoptosis. Int. J. Mol. Sci. 2024, 25, 12619. https://doi.org/10.3390/ijms252312619

AMA Style

Abdouh M, Chen Y, Goyeneche A, Burnier MN. Blue Light-Induced Mitochondrial Oxidative Damage Underlay Retinal Pigment Epithelial Cell Apoptosis. International Journal of Molecular Sciences. 2024; 25(23):12619. https://doi.org/10.3390/ijms252312619

Chicago/Turabian Style

Abdouh, Mohamed, Yunxi Chen, Alicia Goyeneche, and Miguel N. Burnier. 2024. "Blue Light-Induced Mitochondrial Oxidative Damage Underlay Retinal Pigment Epithelial Cell Apoptosis" International Journal of Molecular Sciences 25, no. 23: 12619. https://doi.org/10.3390/ijms252312619

APA Style

Abdouh, M., Chen, Y., Goyeneche, A., & Burnier, M. N. (2024). Blue Light-Induced Mitochondrial Oxidative Damage Underlay Retinal Pigment Epithelial Cell Apoptosis. International Journal of Molecular Sciences, 25(23), 12619. https://doi.org/10.3390/ijms252312619

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop